
OPKO Health, Inc.: Innovating in pharmaceuticals, vaccines, and diagnostic products.
Founded with a mission to improve patient lives through innovative healthcare solutions, OPKO Health, Inc. is a fully-integrated company specializing in the discovery, development, and commercialization of pharmaceuticals, vaccines, and diagnostic products. The company focuses on delivering next-generation solutions for serious diseases across established global markets, leveraging advanced technologies and strategic partnerships with leading pharmaceutical companies.
OPKO Health is led by a highly experienced management team renowned for their expertise in drug development. The company has achieved significant milestones in the healthcare industry, including the successful commercialization of various medical tests and treatments. Through its impactful innovations, OPKO Health continues to make substantial contributions to global healthcare, enhancing the quality of life for patients worldwide.

Merck & CO INC Cedear EAC 5 RE
merck.com

Viatris
viatris.com

Bayer Pharmaceuticals
bayer.com

GSK
gsk.com
Bristol Myers Squibb
bms.com

Quest Diagnostics

Boehringer Ingelheim

Gilead Sciences
gilead.com

ONO Pharmaceutical
Thermo Fisher th
thermofisher.com

Cardinal Health
cardinalhealth.com

Empowered Diagnostics

Myriad Genetics
myriad.com

QuidelOrtho
quidelortho.com

OraSure Technologies
orasure.com
Companies similar to Opko Health include Merck & CO INC Cedear EAC 5 RE, Viatris, Bayer Pharmaceuticals and GSK.
Opko Health was founded in 1991.
Opko Health's headquarters is located in Miami, FL, US.
Opko Health's most recent funding round was for $230M (USD) in January 2024.
As of Jan 3, 2024, Opko Health has raised a total of $436M (USD).
Opko Health has 4,196 employees as of Feb 6, 2024.